RT @tom_marjot: 1: In 2025, look out for a new section in @JHepatology:  "Breakthroughs Beyond the Journal". Editorial-style analyses of pi….

RT @JVLazarus: @EASLnews @AleksanderKrag @FrancqueSven @apdpdiabetes @brennap9 @MajaThiele @schattenbergJ @AlkhouriNaim @marurinella @Fatty….

RT @TerryYip12: New study at @JHepatology unveils how two-step clinical care pathway for #MASLD predicts #MALOs. Many thanks to all collabo….

What’s the best way to implement the 2-step clinical care pathway for evaluating MASLD? Is it as effective as VCTE for all patients? Check out this paper in J Hep: Congrats to @TerryYip12 and the VCTE-Prognosis Study Team! 🎉 #MASLD #ClinicalResearch

A new blood-based biomarker for #MASH has been confirmed in diverse US and Chinese populations. Amazing collaboration among @CUHKMedicine, @UCSDHealth, and Wenzhou Medical University! Read more in Cell Metabolism:

RT @DrLoomba: Call for abstracts for the MetALD Conference in San Diego Nov 14 at Westin Gaslamp Quarter- A star-studded panel of faculty f….

This is probably the first MetALD Conference ever. Thank you, @DrLoomba, for hosting this in San Diego!.

RT @Gut_BMJ: Great new #GUTVideo by Su et al on. "Lactococcus lactis HkyuLL 10 suppresses colorectal tumourigenesis and restores gut microb….

RT @JHepatology: 👋#LiverTwitter. What is your diagnosis❓. 41yo woman: dark urine, scleral icterus, fatigue, shortness of breath, RUQ pain….

Achieving SVR doesn’t mean you’re free from liver cancer. The new AI-Safe-C score can identify patients at residual cancer risk. Stay informed! Congratulations, Huapeng! #Hepatology #LiverCancer #AI.

RT @JHepatology: 🆕Article in press❕. Porto-sinusoidal vascular liver disorder with portal hypertension: Natural History and Long-Term Outco….

RT @JVLazarus: Excited to share our new review: "Food inequity and insecurity and MASLD: burden, challenges, and interventions". https://t.c….

RT @HEP_Journal: REVIEW.Epidemiology, screening, and co-management of type 2 diabetes mellitus and metabolic dysfunction–associated steatot….

RT @MattiasMandorf1: Possibly the most satisfying achievement for physician-scientists: When your proposal stands the test of time & define….

RT @APandT: "Prevalence and prognosis of patients with MASLD-related cirrhosis after an ICU hospitalization in France: A single-centre pros….

RT @BrettEFortuneMD: Important paper 🚨 👇🏻!!!.

RT @APandT: Published open access at "Faecal biomarkers for diagnosis and prediction of disease course in treatment….

RT @JHepatology: Van Gogh-like 2 is essential for the architectural patterning of the mammalian biliary tree. Full text here👉.

RT @APandT: Patients with covert HE has a higher probability of developing overt HE than patients with other causes of neurocognitive impai….

RT @LouisHSLau: Enjoyed the time in 🇰🇷 for #ENDO2024! Honoured to receive the @WorldEndoOrg best abstract award on behalf of our research t….